Home/Filings/4/0001362118-21-000003
4//SEC Filing

Strawn John R Jr 4

Accession 0001362118-21-000003

CIK 0000948320other

Filed

Apr 21, 8:00 PM ET

Accepted

Apr 22, 6:02 PM ET

Size

15.6 KB

Accession

0001362118-21-000003

Insider Transaction Report

Form 4
Period: 2021-04-18
Transactions
  • Exercise/Conversion

    Common Stock, par value $0.01

    2021-04-18$1.00/sh+200,000$200,000203,467 total
  • Exercise/Conversion

    Common Stock, par value $0.01

    2021-04-18$2.00/sh+100,000$200,000283,407 total
  • Tax Payment

    Common Stock, par value $0.01

    2021-04-18$9.97/sh20,060$199,998183,407 total
  • Tax Payment

    Common Stock, par value $0.01

    2021-04-18$9.97/sh20,060$199,998263,347 total
  • Exercise/Conversion

    Option

    2021-04-18200,0000 total
    Exercise: $1.00From: 2011-04-20Exp: 2021-04-20Common Stock, par value $0.01 (200,000 underlying)
  • Exercise/Conversion

    Option

    2021-04-18100,0000 total
    Exercise: $2.00From: 2011-04-20Exp: 2021-04-20Common Stock, par value $0.01 (100,000 underlying)
Holdings
  • Common Stock, par value $0.01

    (indirect: Strawn Pickens LLP)
    60,000
Footnotes (6)
  • [F1]The Amount of Securities Beneficially Owned reflects a correction of an additional 467 shares from previous Form 3/A filing of the reporting person.
  • [F2]Reflects 20,060 shares withheld by issuer to fund the cashless exercise of 200,000 options pursuant to the Reporting Person's Stock Option Agreement.
  • [F3]Reflects 20,060 shares withheld by issuer to fund the cashless exercise of 100,000 options pursuant to the Reporting Person's Stock Option Agreement.
  • [F4]Mr. Strawn has shared voting and dispositive power and as partner of Strawn Pickens LLP he shares a pecuniary interest. The shares were subject to a 1-for-5 reverse stock split in October, 2020.
  • [F5]The original grant of 1,000,000 common stock options was subject to a 1-for-5 reverse stock split in October, 2020. The exercise reported herein is the shares remaining after the split.
  • [F6]The original grant of 500,000 common stock options was subject to a 1-for-5 reverse stock split in October, 2020. The exercise reported herein is the shares remaining after the split.

Issuer

LifeMD, Inc.

CIK 0000948320

Entity typeother

Related Parties

1
  • filerCIK 0001721394

Filing Metadata

Form type
4
Filed
Apr 21, 8:00 PM ET
Accepted
Apr 22, 6:02 PM ET
Size
15.6 KB